药物对比
Chlorpropamide vs Vildagliptin
Chlorpropamide（磺脲类）与 Vildagliptin（DPP-4抑制剂）：Chlorpropamide 有低血糖和体重增加风险；Vildagliptin 副作用较少。选择取决于患者具体情况。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting between sulfonylureas and DPP-4 inhibitors for type 2 diabetes management.
结论
Neither drug is inherently better; the choice between Chlorpropamide and Vildagliptin should be individualized based on patient-specific factors such as kidney function and risk of hypoglycemia.
全部药物对比